The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
ABCG2: A perspective
Open accessAbstract
ABCG2, or Breast Cancer Resistance Protein (BCRP), is an ABC transporter that has been the subject of intense study since its discovery a decade ago. With high normal tissue expression in the brain endothelium, gastrointestinal tract, and placenta, ABCG2 is believed to be important in protection from xenobiotics, regulating oral bioavailability, forming part of the blood-brain barrier, the blood-testis barrier, and the maternal-fetal barrier. Notably, ABCG2 is often expressed in stem cell populations, where it likely plays a role in xenobiotic protection. However, clues to its epigenetic regulation in various cell populations are only beginning to emerge. While ABCG2 overexpression has been demonstrated in cancer cells after in vitro drug treatment, endogenous ABCG2 expression in certain cancers is likely a reflection of the differentiated phenotype of the cell of origin and likely contributes to intrinsic drug resistance. Notably, research into the transporter’s role in cancer drug resistance and its development as a therapeutic target in cancer has lagged. Substrates and inhibitors of the transporter have been described, among them chemotherapy drugs, tyrosine kinase inhibitors, antivirals, HMG-CoA reductase inhibitors, carcinogens, and flavonoids. This broad range of substrates complements the efficiency of ABCG2 as a transporter in laboratory studies and suggests that, while there are redundant mechanisms of xenobiotic protection, the protein is important in normal physiology. Indeed, emerging studies in pharmacology and toxicology assessing polymorphic variants in man, in combination with murine knockout models have confirmed its dynamic role. Work in pharmacology may eventually lead us to a greater understanding of the physiologic role of ABCG2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Self-citationABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
Self-citationLeslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Self-citationCell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
Kartner, N., Riordan, J. R., & Ling, V. (1983) · Science · doi:10.1126/science.6137059 · Cited by 991
The GxxxG motif: A framework for transmembrane helix-helix association
Russ, W. P., & Engelman, D. M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3489 · Cited by 936
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 929
Self-citationAllikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 918
Self-citationJonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 814
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Biedler, J. L., & Riehm, H. (1970) · PubMed · Cited by 747
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
ATP-Binding Cassette Transporters in Bacteria
Davidson, A. L., & Chen, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073626 · Cited by 666
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme
Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., & Schuetz, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313599200 · Cited by 661
EVOLUTION OF THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SUPERFAMILY IN VERTEBRATES
Dean, M., & Annilo, T. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162122 · Cited by 650
Self-citationRole of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Picard, S., Titier, K., Etienne, G., Teilhet, E., Ducint, D., Bernard, M.-A., Lassalle, R., Marit, G., Reiffers, J., Begaud, B., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036012 · Cited by 612
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
Mahon, F.-X., Belloc, F., Lagarde, V., Chollet, C., Moreau-Gaudry, F., Reiffers, J., Goldman, J. M., & Melo, J. V. (2003) · Blood · doi:10.1182/blood.v101.6.2368 · Cited by 538
Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
Akiyama, S.-I., Fojo, A., Hanover, J. A., Pastan, I., & Gottesman, M. M. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534700 · Cited by 529
The Gut as a Barrier to Drug Absorption: Combined Role of Cytochrome P450 3A and P-Glycoprotein
Zhang, Y., & Benet, L. Z. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140030-00002 · Cited by 518
Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., & Sorrentino, B. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192276999 · Cited by 502
Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W., & Greenberger, L. M. (2000) · PubMed · Cited by 487
Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y., & Sugimoto, Y. (2002) · PubMed · Cited by 442
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Self-citationJonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T. C., & Schinkel, A. H. (2005) · Nature Medicine · doi:10.1038/nm1186 · Cited by 423
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
ABCG2: determining its relevance in clinical drug resistance
Robey, R. W., Polgar, O., Deeken, J., To, K. W., & Bates, S. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9042-6 · Cited by 387
Self-citationKantarjian, H., Pasquini, R., Hamerschlak, N., Rousselot, P., Holowiecki, J., Jootar, S., Robak, T., Khoroshko, N., Masszi, T., Skotnicki, A., et al. (2007) · Blood · doi:10.1182/blood-2006-11-056028 · Cited by 377
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., & Bates, S. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601370 · Cited by 368
Self-citationBreedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
Robey, R. W., Steadman, K., Polgar, O., Morisaki, K., Blayney, M., Mistry, P., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3298 · Cited by 350
Self-citationHigh-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
Cisternino, S., Mercier, C., Bourasset, F., Roux, F., & Scherrmann, J.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2033 · Cited by 329
Houghton, P. J., Germain, G. S., Harwood, F. C., Schuetz, J. D., Stewart, C. F., Buchdunger, E., & Traxler, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3344 · Cited by 323
Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect Cells
Özvegy, C., Litman, T., Szakács, G., Nagy, Z., Bates, S., Váradi, A., & Sarkadi, B. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5130 · Cited by 319
Self-citationMizuarai, S., Aozasa, N., & Kotani, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.11669 · Cited by 318
Rabindran, S. K., He, H., Singh, M. S., Brown, E., Collins, K., Annable, T., & Greenberger, L. M. (1998) · PubMed · Cited by 305
Graf, G. A., Li, W.-P., Gerard, R. D., Gelissen, I., White, A., Cohen, J. C., & Hobbs, H. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16000 · Cited by 305
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
de Bruin, M., Miyake, K., Litman, T., Robey, R., & Bates, S. E. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00182-2 · Cited by 298
Self-citationHuls, M., Brown, C. D. A., Windass, A. S., Sayer, R., van den Heuvel, J. J. M. W., Heemskerk, S., Russel, F. G. M., & Masereeuw, R. (2008) · Kidney International · doi:10.1038/sj.ki.5002645 · Cited by 293
Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10100 · Cited by 291
Graf, G. A., Li, W.-P., Gerard, R. D., Gelissen, I., White, A., Cohen, J. C., & Hobbs, H. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216000 · Cited by 283
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germà‐Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 275
de Vries, N. A., Zhao, J., Kroon, E., Buckle, T., Beijnen, J. H., & van Tellingen, O. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1335 · Cited by 270
van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2003) · PubMed · Cited by 269
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
Ross, D. D., Karp, J. E., Chen, T. T., & Doyle, L. A. (2000) · Blood · doi:10.1182/blood.v96.1.365 · Cited by 250
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype*1
SPARREBOOM, A. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.003 · Cited by 241
Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib
Cusatis, G., Gregorc, V., Li, J., Spreafico, A., Ingersoll, R. G., Verweij, J., Ludovini, V., Villa, E., Hidalgo, M., Sparreboom, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj469 · Cited by 241
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
Qadir, M., O'Loughlin, K. L., Fricke, S. M., Williamson, N. A., Greco, W. R., Minderman, H., & Baer, M. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1725 · Cited by 236
Eisenblätter, T., Hüwel, S., & Galla, H.-J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02401-6 · Cited by 232
Single nucleotide polymorphisms modify the transporter activity of ABCG2
Morisaki, K., Robey, R. W., Özvegy-Laczka, C., Honjo, Y., Polgar, O., Steadman, K., Sarkadi, B., & Bates, S. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0931-x · Cited by 230
Self-citationMerino, G., Jonker, J. W., Wagenaar, E., van Herwaarden, A. E., & Schinkel, A. H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010439 · Cited by 228
van Herwaarden, A. E., Wagenaar, E., Merino, G., Jonker, J. W., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01621-06 · Cited by 226
Bailey-Dell, K. J., Hassel, B., Doyle, L. A., & Ross, D. D. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00270-6 · Cited by 225
ABCG2: structure, function and role in drug response
Polgar, O., Robey, R. W., & Bates, S. E. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.1.1 · Cited by 224
Self-citationChen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
Rudin, C. M., Liu, W., Desai, A., Karrison, T., Jiang, X., Janisch, L., Das, S., Ramirez, J., Poonkuzhali, B., Schuetz, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1128 · Cited by 220
Ebert, B., Seidel, A., & Lampen, A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi139 · Cited by 220
Ee, P. L. R., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., & Beck, W. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3583 · Cited by 217
Expression and functional characterization of ABCG2 in brain endothelial cells and vessels
Zhang, W., Mojsilovic-Petrovic, J., Andrade, M. F., Zhang, H., Ball, M., & Stanimirovic, D. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1131fje · Cited by 204
Marchetti, S., de Vries, N. A., Buckle, T., Bolijn, M. J., van Eijndhoven, M. A. J., Beijnen, J. H., Mazzanti, R., van Tellingen, O., & Schellens, J. H. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2250 · Cited by 201
Brendel, C., Scharenberg, C., Dohse, M., Robey, R. W., Bates, S. E., Shukla, S., Ambudkar, S. V., Wang, Y., Wennemuth, G., Burchert, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404638 · Cited by 200
Self-citationMerino, G., Álvarez, A. I., Pulido, M. M., Molina, A. J., Schinkel, A. H., & Prieto, J. G. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008219 · Cited by 199
Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues
Fetsch, P. A., Abati, A., Litman, T., Morisaki, K., Honjo, Y., Mittal, K., & Bates, S. E. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.024 · Cited by 197
Self-citationJamroziak, K., Młynarski, W., Balcerczak, E., Mistygacz, M., Treliǹska, J., Mirowski, M., Bodalski, J., & Robak, T. (2004) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00228.x · Cited by 194
Wilson, C. S. (2006) · Blood · doi:10.1182/blood-2004-12-4633 · Cited by 190
ABCG2 expression, function, and promoter methylation in human multiple myeloma
Turner, J. G., Gump, J. L., Zhang, C., Cook, J. M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M. J., Dalton, W. S., & Sullivan, D. M. (2006) · Blood · doi:10.1182/blood-2005-10-009084 · Cited by 189
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Benderra, Z., Faussat, A.-M., Sayada, L., Perrot, J.-Y., Chaoui, D., Marie, J.-P., & Legrand, O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0795 · Cited by 188
Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens
Enokizono, J., Kusuhara, H., & Sugiyama, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034751 · Cited by 182
Szatmari, I., Vámosi, G., Brazda, P., Balint, B. L., Benko, S., Széles, L., Jeney, V., Özvegy-Laczka, C., Szántó, A., Barta, E., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604890200 · Cited by 180
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
Bakos, É., & Homolya, L. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0160-8 · Cited by 177
Evseenko, D. A., Paxton, J. W., & Keelan, J. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011478 · Cited by 177
Evolution of the vertebrate ABC gene family: analysis of gene birth and death
Annilo, T., Chen, Z.-Q., Shulenin, S., Costantino, J., Thomas, L., Lou, H., Stefanov, S., & Dean, M. (2006) · Genomics · doi:10.1016/j.ygeno.2006.03.001 · Cited by 175
Self-citationGutmann, H., Hruz, P., Zimmermann, C., Beglinger, C., & Drewe, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.031 · Cited by 171
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
Estrogen-Mediated Post transcriptional Down-regulation of Breast Cancer Resistance Protein/ABCG2
Imai, Y., Ishikawa, E., Asada, S., & Sugimoto, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.596.65.2 · Cited by 169
To, K. K. W., Zhan, Z., Litman, T., & Bates, S. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-08 · Cited by 164
Self-citationBart, J., Hollema, H., Groen, H. J. M., de Vries, E. G. E., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W., & van der Graaf, W. T. A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.010 · Cited by 164
Enokizono, J., Kusuhara, H., Ose, A., Schinkel, A. H., & Sugiyama, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019257 · Cited by 163
Effect of ABCG2 genotype on the oral vioavailability of topotecan
Sparreboom, A., Loos, W. J., Burger, H., Sissung, T. M., Verweij, J., Figg, II, Nooter, K., & Gelderblom, H. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.6.1731 · Cited by 162
Zaher, H., Khan, A. A., Palandra, J., Brayman, T. G., Yu, L., & Ware, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050113v · Cited by 162
Akt Signaling Regulates Side Population Cell Phenotype via Bcrp1 Translocation
Mogi, M., Yang, J., Lambert, J.-F., Colvin, G. A., Shiojima, I., Skurk, C., Summer, R., Fine, A., Quesenberry, P. J., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306362200 · Cited by 161
Herwaarden, A. E. V., Wagenaar, E., Karnekamp, B., Merino, G., Jonker, J. W., & Schinkel, A. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi176 · Cited by 161
Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate
Jordanides, N. E., Jorgensen, H. G., Holyoake, T. L., & Mountford, J. C. (2006) · Blood · doi:10.1182/blood-2006-02-003145 · Cited by 158
Gervasoni, J. E., Fields, S. Z., Krishna, S., Baker, M. A., Rosado, M., Thuraisamy, K., Hindenburg, A., & Taub, R. N. (1991) · PubMed · Cited by 156
Hori, S., Ohtsuki, S., Tachikawa, M., Kimura, N., Kondo, T., Watanabe, M., Nakashima, E., & Terasaki, T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02537.x · Cited by 150
Regulation of BCRP/ABCG2 expression by progesterone and 17β-estradiol in human placental BeWo cells
Wang, H., Zhou, L., Gupta, A., Vethanayagam, R. R., Zhang, Y., Unadkat, J. D., & Mao, Q. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00397.2005 · Cited by 149
Dietel, M., Arps, H., Lage, H., & Niendorf, A. (1990) · PubMed · Cited by 149
Lepper, E. R., Nooter, K., Verweij, J., Acharya, M. R., Figg, W. D., & Sparreboom, A. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.2.115 · Cited by 142
Tamura, A., Watanabe, M., Saito, H., Nakagawa, H., Kamachi, T., Okura, I., & Ishikawa, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023556 · Cited by 141
Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status
García‐Closas, M., & Chanock, S. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0975 · Cited by 141
Transport of Glyburide by Placental ABC Transporters: Implications in Fetal Drug Exposure
Gedeon, C., Behravan, J., Koren, G., & Piquette‐Miller, M. (2006) · Placenta · doi:10.1016/j.placenta.2005.11.012 · Cited by 139
Oostendorp, R. L., Buckle, T., Beijnen, J. H., van Tellingen, O., & Schellens, J. H. M. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9138-z · Cited by 137
Liu, W., Baer, M. R., Bowman, M. J., Pera, P., Zheng, X., Morgan, J., Pandey, R. A., & Oseroff, A. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1599 · Cited by 136
Diop, N. K., & Hrycyna, C. A. (2005) · Biochemistry · doi:10.1021/bi0479858 · Cited by 136
Nakagawa, M., Schneider, E., Dixon, K. H., Horton, J., Kelley, K., Morrow, C., & Cowan, K. H. (1992) · PubMed · Cited by 136
Isolation and characterization of an anthracycline-resistant human leukemic cell line.
Bhalla, K. N., Hindenburg, A., Taub, R. N., & Grant, S. (1985) · PubMed · Cited by 133
Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2
McDevitt, C. A., Collins, R. F., Conway, M. A., Modok, S., Storm, J., Kerr, I. D., Ford, R. C., & Callaghan, R. (2006) · Structure · doi:10.1016/j.str.2006.08.014 · Cited by 132
Zhou, L., Naraharisetti, S. B., Wang, H., Unadkat, J. D., Hébert, M. F., & Mao, Q. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041616 · Cited by 131
Sesink, A. L. A., Arts, I. C. W., de Boer, V. C. J., Breedveld, P., Schellens, J. H. M., Hollman, P. C. H., & Rüssel, F. G. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009753 · Cited by 128
Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma
To, K. K. W., Zhan, Z., & Bates, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00650-06 · Cited by 126
Self-citationTo, K. K. W., Polgár, O., Huff, L. M., Morisaki, K., & Bates, S. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0175 · Cited by 125
Self-citationKafka, A., Sauer, G., Jaeger, C., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.5.1117 · Cited by 121
Henriksen, U., Fog, J. U., Litman, T., & Gether, U. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502937200 · Cited by 119
Wang, H., Lee, E., Zhou, L., Leung, P. C. K., Ross, D. D., Unadkat, J. D., & Mao, Q. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041087 · Cited by 116
ABC transporters and inhibitors: new targets, new agents.
Leonard, G. D., Polgár, O., & Bates, S. E. (2002) · PubMed · Cited by 115
Self-citationZamek‐Gliszczynski, M. J., Nezasa, K.-I., Tian, X., Kalvass, J. C., Patel, N. J., Raub, T. J., & Brouwer, K. L. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026955 · Cited by 113
Takada, T., Suzuki, H., Gotoh, Y., & Sugiyama, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003228 · Cited by 113
Olsen, H. G., Nilsen, H., Hayes, B. J., Berg, P. R., Svendsen, M., Lien, S., & Meuwissen, T. H. E. (2007) · BMC Genetics · doi:10.1186/1471-2156-8-32 · Cited by 112
Part II: Management of resistance to imatinib in chronic myeloid leukaemia
Apperley, J. F. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70379-0 · Cited by 111
Mutational Analysis of ABCG2: Role of the GXXXG Motif
Polgár, O., Robey, R. W., Morisaki, K., Dean, M. C., Michejda, C. J., Sauna, Z. E., Ambudkar, S. V., Tarasova, N. I., & Bates, S. E. (2004) · Biochemistry · doi:10.1021/bi0497953 · Cited by 109
Self-citationPollex, E. K., Lubetsky, A., & Koren, G. (2008) · Placenta · doi:10.1016/j.placenta.2008.05.001 · Cited by 106
Cole, S., Downes, H., & Slovak, M. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.9 · Cited by 106
Breast Cancer Resistance Protein 1 Limits Fetal Distribution of Nitrofurantoin in the Pregnant Mouse
Zhang, Y., Wang, H., Unadkat, J. D., & Mao, Q. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018044 · Cited by 105
Pulido, M. M., Molina, A. J., Merino, G., Mendoza, G., Prieto, J. G., & Álvarez, A. I. (2006) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2006.00744.x · Cited by 102
Mizuno, N., Suzuki, M., Kusuhara, H., Suzuki, H., Takeuchi, K., Niwa, T., Jonker, J. W., & Sugiyama, Y. (2004) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)02969-6 · Cited by 99
Bihorel, S., Camenisch, G., Lemaire, M., & Scherrmann, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04808.x · Cited by 98
Shukla, S., Sauna, Z. E., & Ambudkar, S. V. (2007) · Leukemia · doi:10.1038/sj.leu.2404897 · Cited by 96
Štaud, F., Vacková, Z., Pospěchová, K., Pávek, P., Čečková, M., Libra, A., Cygalova, L. H., Nachtigal, P., & Fendrich, Z. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105023 · Cited by 95
Knutsen, T., Rao, V. K., Ried, T., Mickley, L. A., Schneider, E., Miyake, K., Ghadimi, Β. M., Padilla‐Nash, H. M., Pack, S., Greenberger, L. M., et al. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200001)27:1<110::aid-gcc14>3.3.co;2-w · Cited by 93
Self-citationYang, J. C., Horton, J. K., Cowan, K. H., & Schneider, E. (1995) · PubMed · Cited by 89
Gedeon, C., Anger, G. J., Piquette‐Miller, M., & Koren, G. (2007) · Placenta · doi:10.1016/j.placenta.2007.08.004 · Cited by 89
Ferrao, P. T., Frost, M. J., Siah, S.-P., & Ashman, L. K. (2003) · Blood · doi:10.1182/blood-2003-01-0083 · Cited by 88
Yin, L., Castagnino, P. A., & Assoian, R. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2545 · Cited by 84
Zamek‐Gliszczynski, M. J., Hoffmaster, K. A., Humphreys, J. E., Tian, X., Nezasa, K.-I., & Brouwer, K. L. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101840 · Cited by 81
Miwa, M., Tsukahara, S., Ishikawa, E., Asada, S., Imai, Y., & Sugimoto, Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.11484 · Cited by 80
Borght, S. V., Libbrecht, L. J., Katoonizadeh, A., van Pelt, J. F., Cassiman, D. M., Nevens, F., Lommel, A. V., Petersen, B. E., Fevery, J., Jansen, P. L. M., et al. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6912.2006 · Cited by 78
Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells
Mukai, M., Che, X., Furukawa, T., Sumizawa, T., Aoki, S., Ren, X., Haraguchi, M., Sugimoto, Y., Kobayashi, M., Takamatsu, H., et al. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01482.x · Cited by 76
Bihorel, S., Camenisch, G., Lemaire, M., & Scherrmann, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9278-4 · Cited by 72
Nakanishi, T., Bailey-Dell, K. J., Hassel, B. A., Shiozawa, K., Sullivan, D. M., Turner, J. G., & Ross, D. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4572 · Cited by 72
Tamura, A., Onishi, Y., An, R., Koshiba, S., Wakabayashi, K., Hoshijima, K., Priebe, W., Yoshida, T., Kometani, S., Matsubara, T., et al. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.428 · Cited by 72
Myllynen, P. K., Kummu, M., Kangas, T., Ilves, M., Immonen, E., Rysä, J., Pirilä, R., Lastumäki, A., & Vähäkangas, K. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.07.006 · Cited by 70
Ejendal, K. F. K., Diop, N. K., Schweiger, L. C., & Hrycyna, C. A. (2006) · Protein Science · doi:10.1110/ps.051998406 · Cited by 69
Mizuno, N., Takahashi, T., Kusuhara, H., Schuetz, J. D., Niwa, T., & Sugiyama, Y. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016352 · Cited by 65
Seamon, J. A., Rugg, C. A., Emanuel, S. L., Calcagno, A. M., Ambudkar, S. V., Middleton, S. A., Butler, J., Borowski, V., & Greenberger, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0339 · Cited by 64
Short Communication: A Polymorphism in ABCG2 in Bos indicus and Bos taurus Cattle Breeds
Ron, M., Cohen, M. W., Peter, C., Weller, J. I., & Erhardt, G. (2006) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(06)72542-5 · Cited by 62
Henriksen, U., Gether, U., & Litman, T. (2005) · Journal of Cell Science · doi:10.1242/jcs.01729 · Cited by 61
Aust, S., Obrist, P., Jaeger, W., Klimpfinger, M., Tucek, G., Wrba, F., Penner, E., & Thalhammer, T. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700127 · Cited by 59
Enokizono, J., Kusuhara, H., & Sugiyama, Y. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012567 · Cited by 47
Mutational Studies of G553 in TM5 of ABCG2: A Residue Potentially Involved in Dimerization
Polgár, O., Özvegy‐Laczka, C., Robey, R. W., Morisaki, K., Okada, M., Tamaki, A., Köblös, G., Elkind, N. B., Ward, Y., Dean, M. C., et al. (2006) · Biochemistry · doi:10.1021/bi0521590 · Cited by 40
Self-citationMickley, L. A., Jain, P. K., Miyake, K., Schriml, L. M., Rao, K., Fojo, T., Bates, S. E., & Dean, M. C. (2001) · Mammalian Genome · doi:10.1007/s003350010237 · Cited by 35
Self-citation
Cited by
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
The Blood-Testis Barrier and Its Implications for Male Contraception
Cheng, C. Y., & Mruk, D. D. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.002790 · Cited by 927
Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813
Abdullahi, W., Tripathi, D., & Ronaldson, P. T. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00095.2018 · Cited by 613
Structural and Mechanistic Principles of ABC Transporters
Thomas, C., & Tampé, R. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011520-105201 · Cited by 563
Metadata
- Authors
- Robey, R. W., To, K. K. K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., & Bates, S. E.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 61
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1966178564
- Cited by
- 449
- References
- 152
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.